Therapeutic Asset Ratings
175 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Inotuzumab Ozogamicin
Burkitt Lymphoma
SWOG Cancer Research Network
P1/2
B
(57)
Nogapendekin Alfa
Non-Small Cell Lung Carcinoma
SWOG Cancer Research Network
P2/3
B
(57)
Calaspargase Pegol
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
CCC
(55)
Inno-206
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
CCC
(55)
Nogapendekin Alfa
Lung Cancer
SWOG Cancer Research Network
P2/3
CCC
(55)
Eflornithine
Colorectal Neoplasm
SWOG Cancer Research Network
P3
CCC
(54)
LISPRO-PH20 COMPONENT RHUPH20
Plasma Cell Myeloma
SWOG Cancer Research Network
P3
CCC
(54)
Daunorubicin
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
CCC
(54)
MERCAPTOPURINE ANHYDROUS
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
CCC
(54)
THIOGUANINE ANHYDROUS
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
CCC
(54)
Sulindac
Colorectal Neoplasm
SWOG Cancer Research Network
P3
CCC
(53)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Extensive Stage Lung Small Cell Carcinoma
SWOG Cancer Research Network
P2
CCC
(53)
Axicabtagene Ciloleucel
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Binimetinib
Acral Lentiginous Melanoma
SWOG Cancer Research Network
P2
CCC
(53)
Binimetinib
Mucosal Melanoma
SWOG Cancer Research Network
P2
CCC
(53)
Blinatumomab
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P2
CCC
(53)
Capecitabine
Metastatic Malignant Neoplasm in the Liver
SWOG Cancer Research Network
P2
CCC
(53)
Ceralasertib
Small Cell Lung Carcinoma
SWOG Cancer Research Network
P2
CCC
(53)
Cyclophosphamide
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Encorafenib
Acral Lentiginous Melanoma
SWOG Cancer Research Network
P2
CCC
(53)
Encorafenib
Mucosal Melanoma
SWOG Cancer Research Network
P2
CCC
(53)
Fludarabine
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Ibrutinib
Extensive Stage Lung Small Cell Carcinoma
SWOG Cancer Research Network
P2
CCC
(53)
INTERFERON ALFA-2B
CD19+ Acute Leukemia
SWOG Cancer Research Network
P2
CCC
(53)
INTERFERON ALFA-2B
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P2
CCC
(53)
Showing 126 to 150 of 175 assets
Previous
Page 6 of 7
Next